BUDGET IMPACT ANALYSIS OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN COLOMBIA

被引：0

作者：

Patino, A. ^{[1
]}

Karpf, E. ^{[1
]}

Londono, D. ^{[2
]}

机构：

[1] Novartis Colombia, Bogota, Colombia

[2] Fdn Santa Fe Bogota, Bogota, Colombia

来源：

VALUE IN HEALTH | 2017年 / 20卷 / 09期

关键词：

D O I：

10.1016/j.jval.2017.08.2662

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PRS6

引用

页码：A888 / A888

页数：1

共 50 条

[1] A BUDGET IMPACT ANALYSIS OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN COLOMBIA
Giraldo, L. F.
Ariza, J. G.
Acosta, T.
Pinzon, J. F.
VALUE IN HEALTH, 2012, 15 (04) : A53 - A53
[2] Budget impact model of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease in Italy based on the FLAME study
Aiello, Andrea
Ritrovato, Daniela
Pitotti, Claudia
GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2018,
[3] Comparative effectiveness of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease
Cazzola, Mario
Rogliani, Paola
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (07) : 627 - 636
[4] Treatment of Chronic Obstructive Pulmonary Disease by Dual Bronchodilation with Coformulation of Indacaterol/Glycopyrronium
Pelaia, Girolamo
Maselli, Rosario
Matera, Maria Gabriella
PHARMACOLOGY, 2014, 94 (5-6) : 249 - 258
[5] QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary disease
Matera, Maria Gabriella
Rogliani, Paola
Cazzola, Mario
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (07) : 1079 - 1090
[6] INDACATEROL FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Cazzola, M.
Proietto, A.
Matera, M. G.
DRUGS OF TODAY, 2010, 46 (03) : 139 - 150
[7] COST-EFFECTIVENESS OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN BRAZIL
Tozato, C.
Suzuki, C.
VALUE IN HEALTH, 2018, 21 : S411 - S411
[8] The role of indacaterol for chronic obstructive pulmonary disease (COPD)
Cazzola, Mario
Bardaro, Floriana
Stirpe, Emanuele
JOURNAL OF THORACIC DISEASE, 2013, 5 (04) : 559 - 566
[9] Population health impact of Indacaterol/Glycopyrronium over 4 years in chronic obstructive pulmonary disease
Gutzwiller, Florian S.
Kostikas, Konstantinos
Gruen, Emilie
Sekharan, Manisha
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[10] BUDGET IMPACT MODEL OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF COPD IN ITALY BASED ON FLAME STUDY
Pitotti, C.
Burke, C.
VALUE IN HEALTH, 2016, 19 (07) : A550 - A550

← 1 2 3 4 5 →